2023 annual financial data
Krystal Biotech 2023 Operating margin
Krystal Biotech 2023 operating margin with verified reported values.
Direct answer
Operating margin was -216.43%.
Operating income was -109,727,000 USD and net income was 10,932,000 USD.
Operating cash flow was -88,804,000 USD.
Get free Krystal Biotech email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 50,699,000 USD
- Operating income
- -109,727,000 USD
- Net income
- 10,932,000 USD
- Operating cash flow
- -88,804,000 USD